Rut Mara Arteaga Ojeda

Mrs. Rut Mara Arteaga Ojeda

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2026 in Agronomy
Verified
Journal Article
Open access
PDF file
Rut Mara Arteaga OjedaRut Mara Arteaga Ojeda
Rut Mara Arteaga Ojeda
CLClaudia Patricia Larralde-Corona
Claudia Patricia Larralde-Corona
SCSilvia Cometta
Silvia Cometta
JNJose Alberto Narvaez-Zapata
Jose Alberto Narvaez-Zapata
Biological control agents (BCAs) have emerged as a key strategy to mitigate maize diseases while reducing dependence on synthetic agrochemicals, which pose risks to human health, ecosystems, and microbial diversity. This review synthesizes advances from 63 research articles published between 2020 and 2025, selected through a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) approach to capture studies with in vitro, greenhouse, or field validation. The analysis highlights major fungal and bacterial threats to maize production and evaluates BCAs, including Bacillus, Trichoderma, Streptomyces, and entomopathogenic or endophytic microorganisms, tested across multiple experimental levels. Results show that many agents demonstrate strong antagonism under controlled conditions, promoting plant growth, reducing pathogen incidence, and lowering mycotoxin contamination. Field trials, however, reveal inconsistent performance due to environmental variability, formulation instability, and incomplete understanding of strain-specific mechanisms. Emerging approaches such as microbial consortia, metabolite-based biocontrol, biochar–microbe combinations, and evaluations under dual-stress conditions offer promising avenues to improve reliability and expand applicability. Overall, the review underscores that although microbial biocontrol holds substantial potential for sustainable maize protection, progress toward scalable implementation requires integrating omics-based characterization, optimized formulations, genotype-specific evaluations, and multi-season field trials to bridge the gap between laboratory efficacy and field performance.